D.W. Erkelens

3.6k total citations
85 papers, 2.9k citations indexed

About

D.W. Erkelens is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, D.W. Erkelens has authored 85 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 56 papers in Endocrinology, Diabetes and Metabolism, 36 papers in Surgery and 26 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in D.W. Erkelens's work include Diabetes, Cardiovascular Risks, and Lipoproteins (42 papers), Lipoproteins and Cardiovascular Health (22 papers) and Lipid metabolism and disorders (20 papers). D.W. Erkelens is often cited by papers focused on Diabetes, Cardiovascular Risks, and Lipoproteins (42 papers), Lipoproteins and Cardiovascular Health (22 papers) and Lipid metabolism and disorders (20 papers). D.W. Erkelens collaborates with scholars based in Netherlands, United States and Canada. D.W. Erkelens's co-authors include Tjerk W.A. de Bruin, M. Castro Cabezas, T W de Bruin, Hans Jansen, Marleen M. J. van Greevenbroek, Manuel Castro Cabezas, S. Meijssen, Wouter Kortlandt, L A Kock and Constantijn J.M. Halkes and has published in prestigious journals such as The Lancet, JAMA and Journal of Clinical Investigation.

In The Last Decade

D.W. Erkelens

83 papers receiving 2.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
D.W. Erkelens Netherlands	32	1.5k	1.2k	788	497	460	85	2.9k
Patricia J. Blanche United States	28	1.5k 1.0×	1.3k 1.1×	475 0.6×	618 1.2×	310 0.7×	52	2.8k
T Kuusi Finland	30	1.7k 1.1×	1.1k 0.9×	572 0.7×	408 0.8×	333 0.7×	49	2.7k
E. Windler Germany	25	1.3k 0.8×	1.2k 1.0×	569 0.7×	807 1.6×	506 1.1×	82	3.1k
Paul-J. Lupien Canada	19	1.5k 1.0×	1.1k 0.9×	757 1.0×	437 0.9×	584 1.3×	31	3.0k
G. Cazzolato Italy	25	1.4k 0.9×	1.6k 1.4×	542 0.7×	539 1.1×	432 0.9×	69	3.4k
David M. Capuzzi United States	31	1.0k 0.7×	1.5k 1.2×	404 0.5×	618 1.2×	345 0.8×	75	3.3k
Jean Bergeron Canada	29	989 0.7×	1.3k 1.1×	620 0.8×	512 1.0×	466 1.0×	80	2.9k
G. H. Tomkin Ireland	30	1.1k 0.8×	930 0.8×	441 0.6×	574 1.2×	325 0.7×	99	2.5k
Dorothy Bedford United Kingdom	22	1.2k 0.8×	875 0.7×	594 0.8×	342 0.7×	417 0.9×	35	2.0k
Fred H. Faas United States	18	2.1k 1.4×	2.0k 1.7×	866 1.1×	798 1.6×	476 1.0×	47	4.0k

Countries citing papers authored by D.W. Erkelens

Since Specialization

Citations

This map shows the geographic impact of D.W. Erkelens's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D.W. Erkelens with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D.W. Erkelens more than expected).

Fields of papers citing papers by D.W. Erkelens

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D.W. Erkelens. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D.W. Erkelens. The network helps show where D.W. Erkelens may publish in the future.

Co-authorship network of co-authors of D.W. Erkelens

This figure shows the co-authorship network connecting the top 25 collaborators of D.W. Erkelens. A scholar is included among the top collaborators of D.W. Erkelens based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D.W. Erkelens. D.W. Erkelens is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Erkelens, D.W.. (2015). Normal and Abnormal Metabolism of Lipoproteins. Current problems in dermatology. 20. 45–53.

Beek, André P. van, et al.. (2004). Sex steroids and plasma lipoprotein levels in healthy women: the importance of androgens in the estrogen-deficient state. Metabolism. 53(2). 187–192. 14 indexed citations

Wijk, J.P.H. van, Constantijn J.M. Halkes, D.W. Erkelens, & Manuel Castro Cabezas. (2003). Fasting and daylong triglycerides in obesity with and without type 2 diabetes. Metabolism. 52(8). 1043–1049. 52 indexed citations

Twickler, Th.B., Geesje M. Dallinga‐Thie, Frank L.J. Visseren, et al.. (2003). Induction of Postprandial Inflammatory Response in Adult Onset Growth Hormone Deficiency Is Related to Plasma Remnant-Like Particle-Cholesterol Concentration. The Journal of Clinical Endocrinology & Metabolism. 88(3). 1228–1233. 24 indexed citations

Meijssen, S., et al.. (2001). Insulin Mediated Inhibition of Hormone Sensitive Lipase Activityin Vivoin Relation to Endogenous Catecholamines in Healthy Subjects. The Journal of Clinical Endocrinology & Metabolism. 86(9). 4193–4197. 31 indexed citations

Twickler, Th.B., Geesje M. Dallinga‐Thie, P. M. J. Zelissen, H. P. F. Koppeschaar, & D.W. Erkelens. (2001). The atherogenic plasma remnant‐like particle cholesterol concentration is increased in the fasting and postprandial state in active acromegalic patients. Clinical Endocrinology. 55(1). 69–75. 17 indexed citations

Greevenbroek, Marleen M. J. van, D.W. Erkelens, & Tjerk W.A. de Bruin. (2000). Caco-2 cells secrete two independent classes of lipoproteins with distinct density: effect of the ratio of unsaturated to saturated fatty acid. Atherosclerosis. 149(1). 25–31. 21 indexed citations

Greevenbroek, Marleen M. J. van, et al.. (1998). Lipoprotein secretion by intestinal Caco-2 cells is affected differently by trans and cis unsaturated fatty acids: effect of carbon chain length and position of the double bond1. American Journal of Clinical Nutrition. 68(3). 561–567. 21 indexed citations

Henderson, Howard, Saskia M. Bijvoet, Taco Bruin, et al.. (1998). Ile225Thr loop mutation in thelipoprotein lipase (LPL) gene is a de novo event. American Journal of Medical Genetics. 78(4). 313–316. 13 indexed citations

10.

Cabezas, Manuel Castro, Tjerk W.A. de Bruin, H.E. Westerveld, Ellen Meijer, & D.W. Erkelens. (1998). Delayed chylomicron remnant clearance in subjects with heterozygous familial hypercholesterolaemia. Journal of Internal Medicine. 244(4). 299–307. 58 indexed citations

11.

Greevenbroek, Marleen M. J. van, Gerrit van Meer, D.W. Erkelens, & Tjerk W.A. de Bruin. (1996). Effects of saturated, mono-, and polyunsaturated fatty acids on the secretion of apo B containing lipoproteins by Caco-2 cells. Atherosclerosis. 121(1). 139–150. 75 indexed citations

12.

Kock, L A, et al.. (1996). In vitro lipolysis of human VLDL: Effect of different VLDL compositions in normolipidemia, familial combined hyperlipidemia and familial hypertriglyceridemia. Atherosclerosis. 121(1). 75–84. 18 indexed citations

13.

Smit, Johannes W. A., Karel J. van Erpecum, Piero Portincasa, et al.. (1995). Effects of simvastatin and cholestyramine on bile lipid composition and gall bladder motility in patients with hypercholesterolaemia.. Gut. 37(5). 654–659. 14 indexed citations

14.

Smit, Johannes W. A., Gerard H. Jansen, Tjerk W.A. de Bruin, & D.W. Erkelens. (1995). Treatment of combined hyperlipidemia with fluvastatin and gemfibrozil, alone or in combination, does not induce muscle damage. The American Journal of Cardiology. 76(1-2). 126A–128A. 40 indexed citations

15.

Smit, Johannes W. A., et al.. (1995). Effects of alcohol consumption on pharmacokinetics, efficacy, and safety of fluvastatin. The American Journal of Cardiology. 76(1-2). 89A–96A. 17 indexed citations

16.

Cabezas, M. Castro, T W de Bruin, Harold W. de Valk, et al.. (1993). Impaired fatty acid metabolism in familial combined hyperlipidemia. A mechanism associating hepatic apolipoprotein B overproduction and insulin resistance.. Journal of Clinical Investigation. 92(1). 160–168. 173 indexed citations

17.

Kastelein, John J.P., P. Haydn Pritchard, D.W. Erkelens, et al.. (1992). Familial high‐density‐lipoprotein deficiency causing corneal opacities (fish eye disease) in a family of Dutch descent. Journal of Internal Medicine. 231(4). 413–419. 20 indexed citations

18.

Kortlandt, Wouter, et al.. (1992). Glycated low density lipoprotein catabolism is increased in rabbits with alloxan-induced diabetes mellitus. Diabetologia. 35(3). 202–207. 21 indexed citations

19.

Joles, J.A., et al.. (1991). Hyperlipoproteinemia in one-year-old analbuminemic rats. Atherosclerosis. 88(1). 35–47. 21 indexed citations

20.

Erkelens, D.W. & Robin P.F. Dullaart. (1988). In Vivo Evidence for Cholesterol Ester and Triglyceride Exchange between High Density Lipoprotein and Infused Triglyceride Rich Particles in Abetalipoproteinemia. Advances in experimental medicine and biology. 243. 247–253. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact